These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9223133

  • 1. Long-term effects of Semliki Forest virus infection in the mouse central nervous system.
    Donnelly SM, Sheahan BJ, Atkins GJ.
    Neuropathol Appl Neurobiol; 1997 Jun; 23(3):235-41. PubMed ID: 9223133
    [Abstract] [Full Text] [Related]

  • 2. Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice.
    Smyth JM, Sheahan BJ, Atkins GJ.
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2575-83. PubMed ID: 2174955
    [Abstract] [Full Text] [Related]

  • 3. The inflammatory response to nonfatal Sindbis virus infection of the nervous system is more severe in SJL than in BALB/c mice and is associated with low levels of IL-4 mRNA and high levels of IL-10-producing CD4+ T cells.
    Rowell JF, Griffin DE.
    J Immunol; 1999 Feb 01; 162(3):1624-32. PubMed ID: 9973422
    [Abstract] [Full Text] [Related]

  • 4. Immune responses, and autoimmune outcome, during virus infection of the central nervous system.
    Mokhtarian F, Shi Y, Zhu PF, Grob D.
    Cell Immunol; 1994 Aug 01; 157(1):195-210. PubMed ID: 7518751
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice.
    Chang JR, Zaczynska E, Katsetos CD, Platsoucas CD, Oleszak EL.
    Virology; 2000 Dec 20; 278(2):346-60. PubMed ID: 11118358
    [Abstract] [Full Text] [Related]

  • 6. Virus tropism, distribution, persistence and pathology in the corpus callosum of the Semliki Forest virus-infected mouse brain: a novel system to study virus-oligodendrocyte interactions.
    Fazakerley JK, Cotterill CL, Lee G, Graham A.
    Neuropathol Appl Neurobiol; 2006 Aug 20; 32(4):397-409. PubMed ID: 16866985
    [Abstract] [Full Text] [Related]

  • 7. The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo.
    Thomson M, White CL, Dimmock NJ.
    Virology; 1998 Feb 15; 241(2):215-23. PubMed ID: 9499796
    [Abstract] [Full Text] [Related]

  • 8. The significance of the 3'-nontranslated region and E2 amino acid mutations in the virulence of Semliki Forest virus in mice.
    Santagati MG, Määttä JA, Röyttä M, Salmi AA, Hinkkanen AE.
    Virology; 1998 Mar 30; 243(1):66-77. PubMed ID: 9527916
    [Abstract] [Full Text] [Related]

  • 9. Pathogenesis of Semliki Forest virus encephalitis.
    Fazakerley JK.
    J Neurovirol; 2002 Dec 30; 8 Suppl 2():66-74. PubMed ID: 12491154
    [Abstract] [Full Text] [Related]

  • 10. mRNA expression of proinflammatory cytokines in mouse CNS correlates with replication rate of semliki forest virus but not with the strain of viral proteins.
    Tuittila M, Nygårdas P, Hinkkanen A.
    Viral Immunol; 2004 Dec 30; 17(2):287-97. PubMed ID: 15279706
    [Abstract] [Full Text] [Related]

  • 11. Use of quantitative real-time PCR (qRT-PCR) to measure cytokine transcription and viral load in murine cytomegalovirus infection.
    Tang-Feldman YJ, Wojtowicz A, Lochhead GR, Hale MA, Li Y, Pomeroy C.
    J Virol Methods; 2006 Feb 30; 131(2):122-9. PubMed ID: 16140399
    [Abstract] [Full Text] [Related]

  • 12. Selective downregulation of Th1 response by Linomide reduces autoimmunity but increases susceptibility to viral infection in BALB/c and SJL mice.
    Erälinna JP, Röyttä M, Hukkanen V, Zinhu D, Salmi AA, Salonen R.
    J Neuroimmunol; 1998 Aug 01; 88(1-2):165-76. PubMed ID: 9688338
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Regulation of Semliki Forest virus RNA replication: a model for the control of alphavirus pathogenesis in invertebrate hosts.
    Kim KH, Rümenapf T, Strauss EG, Strauss JH.
    Virology; 2004 May 20; 323(1):153-63. PubMed ID: 15165827
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The type I interferon system protects mice from Semliki Forest virus by preventing widespread virus dissemination in extraneural tissues, but does not mediate the restricted replication of avirulent virus in central nervous system neurons.
    Fragkoudis R, Breakwell L, McKimmie C, Boyd A, Barry G, Kohl A, Merits A, Fazakerley JK.
    J Gen Virol; 2007 Dec 20; 88(Pt 12):3373-3384. PubMed ID: 18024907
    [Abstract] [Full Text] [Related]

  • 17. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations.
    Rodriguez M, Roos RP, McGavern D, Zoecklein L, Pavelko K, Sang H, Lin X.
    Virology; 2000 Sep 15; 275(1):9-19. PubMed ID: 11017783
    [Abstract] [Full Text] [Related]

  • 18. Induction of activator protein-1 and nuclear factor-kappaB as a prerequisite for disease development in susceptible SJL/J mice after theiler murine encephalomyelitis.
    Gerhauser I, Ulrich R, Alldinger S, Baumgärtner W.
    J Neuropathol Exp Neurol; 2007 Sep 15; 66(9):809-18. PubMed ID: 17805011
    [Abstract] [Full Text] [Related]

  • 19. Vaccination with recombinant Semliki Forest virus particles expressing translation initiation factor 3 of Brucella abortus induces protective immunity in BALB/c mice.
    Cabrera A, Sáez D, Céspedes S, Andrews E, Oñate A.
    Immunobiology; 2009 Sep 15; 214(6):467-74. PubMed ID: 19150742
    [Abstract] [Full Text] [Related]

  • 20. The susceptibility of mice to immune-mediated neurologic disease correlates with the degree to which their lymphocytes resist the effects of brain-derived gangliosides.
    Irani DN.
    J Immunol; 1998 Sep 15; 161(6):2746-52. PubMed ID: 9743332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.